Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 8Active not recruiting 6Not yet recruiting 5Completed 5Terminated 3Unknown 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 11Breast 3Thoracic 2Plasma cell 2Lymphoid 2Gynecologic 2Genitourinary 2Other neoplasm 1Other hematologic neoplasm 1Head & Neck 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 133Cisplatin 130Pemetrexed 114Docetaxel 79Drug Therapy 61Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 35Vinorelbine 31Nivolumab 31Radiosurgery 30sintilimab 29aumolertinib 25endostar protein 24durvalumab 24atezolizumab 23Endostatins 22Blood Specimen Collection 19toripalimab 18Immune Checkpoint Inhibitors 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Observation × Thoracic × Clear all
NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Sun Yat-sen University

Phase 2 Unknown
264 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01301560 2011-02-23

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Samsung Medical Center

Phase 3 Unknown
176 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡